Navigation Links
Much Ado About Herbicide Sprays?

A new study investigating the spraying of Agent Orange and many other herbicides at a New Brunswick army// base has shown that, only those who are in direct contact with the spray, for instance people involved in mixing, spraying, and clearing of brush, are exposed to long term health risks, due to the presence of contaminants in the spray.

The finding follows a series of scientific reports, communicating potential health risks due to the extensive spraying of chemical herbicides in the military training base in Canada.

The harmful substances found in defoliants could pose a health risk to those who are directly involved in the spraying activity. The researchers confirmed that people who live in the surrounding areas or those who have been trained at the base, are not under any health risk.

Dennis Furlong, co-coordinator of the fact-finding mission said, "The soldiers training there today are safe. Historically, people living in the vicinity of Base Gage town had negligible risks. The people who were on the base during the process of this spray appear to have negligible risks, unless they were in direct contact with the product, delivery of the product or exposure to the product. Then they may have an augmented risk."

The contaminants in the sprays, dioxin and hexachlorobenzene, could pose potential health problems and trigger chronic illnesses such as cancer, hormonal problems, or even reproductive problems. Officials working in the base are unable to estimate the precise number of people who could have exposed themselves to risk, due to contact with the sprays.//

"We have the complete results of who might have been on the base from 1952 to present, but we don't have the number of folks who might have been in the training area at the time during our annual spray. We're trying to make it more precise." said Col. Ryan Jestin, base commander.


'"/>




Page: 1

Related medicine news :

1. Breast Cancer Survivors Worry About Infertility
2. Breast Cancer Survivors Worry About Infertility
3. Improving Lighting Could Bring About A Change In Alzheimers Patients
4. Poll Finds Many Americans Misinformed About Cancer
5. Poll Finds Many Americans Misinformed About Cancer
6. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
7. Scientists Develop New Technology To Find About Human Ancestors’ Teet
8. WHO Steps Up To Create A Public Awareness About The Consequences Of Exposure To Radon
9. Worried About The Sensitive Skin Of Your 2 Year Old? Fetal Skin Cells To Offer Help
10. Internet Helps Patients In Finding Info About Their Childrens Health Conditions
11. More About The Coffee Bean Than Just A Heavenly Taste and Smell
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Much Ado About Herbicide Sprays

Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10Childrens Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 62578 1Childrens Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 62578 2Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 62575 1Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 62575 2VIDEO from Medialink and the American Nurses Association 28ANA 29 3A American Nurses Association Urges All Americans to Take Part in Health Care Refo 62572 1VIDEO from Medialink and the American Nurses Association 28ANA 29 3A American Nurses Association Urges All Americans to Take Part in Health Care Refo 62572 2